Frank Dolan

The pharma field sees launches as key. Launches set brand paths. A

In today’s shifting health care, pharma firms join digital health. Innovation joins

In today’s healthcare scene, pharma firms work with many groups. Each group

In a world of drug tests, trials must show all lives. Experts

In today’s health field, change hits fast. HCPs learn new things. Georgia

In today’s fast pharma scene, brands act. Customer talk must hit, feel

The pharmaceutical industry is always in flux, driven by innovation, competition, and

Duchenne muscular dystrophy harms boys. It makes muscles weak. It stops movement.

Artificial intelligence (AI) shifts U.S. healthcare. AI touches care, tests, and drug

The inaugural phase saw Robert F. Kennedy Jr. assume health secretary duties

In recent years, the mounting pressure to lower drug prices has prompted

The pharmaceutical landscape is witnessing significant changes with the recent implementation of

In a significant shift aimed at enhancing its competitive edge in the

In an era where convenience and efficiency dictate consumer preferences, General Medicine,

Bayer’s recent Phase 3 clinical trial for its innovative blood-thinner, asundexian, has

The recent appointment of Richard Pazdur as the head of the FDA’s

The landscape of Alzheimer’s treatment took a notable downturn recently when Johnson

Bayer has recently made headlines in the biopharma sector with groundbreaking results

Navigating the complex landscape of pharmaceutical development requires a deep understanding of

Eli Lilly has cemented its place in pharmaceutical history by reaching an